全文获取类型
收费全文 | 690篇 |
免费 | 28篇 |
国内免费 | 20篇 |
专业分类
儿科学 | 4篇 |
妇产科学 | 17篇 |
基础医学 | 79篇 |
口腔科学 | 13篇 |
临床医学 | 40篇 |
内科学 | 66篇 |
神经病学 | 257篇 |
特种医学 | 34篇 |
外科学 | 55篇 |
综合类 | 29篇 |
预防医学 | 40篇 |
眼科学 | 5篇 |
药学 | 60篇 |
中国医学 | 15篇 |
肿瘤学 | 24篇 |
出版年
2023年 | 47篇 |
2022年 | 36篇 |
2021年 | 79篇 |
2020年 | 64篇 |
2019年 | 21篇 |
2018年 | 19篇 |
2017年 | 37篇 |
2016年 | 31篇 |
2015年 | 33篇 |
2014年 | 73篇 |
2013年 | 23篇 |
2012年 | 38篇 |
2011年 | 20篇 |
2010年 | 53篇 |
2009年 | 40篇 |
2008年 | 8篇 |
2007年 | 20篇 |
2006年 | 14篇 |
2005年 | 9篇 |
2004年 | 5篇 |
2003年 | 9篇 |
2002年 | 4篇 |
2001年 | 7篇 |
2000年 | 6篇 |
1999年 | 7篇 |
1998年 | 13篇 |
1997年 | 5篇 |
1996年 | 14篇 |
1994年 | 1篇 |
1993年 | 2篇 |
排序方式: 共有738条查询结果,搜索用时 15 毫秒
1.
BackgroundNowadays surgery remains the gold standard of treatment for tongue cancer. Via a more clear and precise terminology, the glossectomy classification by Ansarin et al. facilitates shared communication between surgeons, allowing comparison between published research and improving surgical practice and patient care. To establish the association of glossectomies, according to their classification by Ansarin et al. with overall survival (OS), disease-free survival (DSF), and cause-specific survival (CSS) in tongue cancer, we conducted a systemic retrospective study on 300 consecutive patients affected by primary oral tongue cancer and treated with surgery at the European Institute of Oncology, IRCCS (IEO).MethodsThree hundred patients with tongue squamous cell carcinoma and treated at the Division of Otorhinolaryngology and Head and Neck Surgery of the European Institute of Oncology, IRCCS were cataloged according to the glossectomy classification. OS, DFS, and CSS were compared by surgical treatments.ResultsOS-5yrs was 80% for the type I glossectomy group, 75% for type II, 65% for type III, and 35% for type IV-V. DFS-5yrs was 74%, 60%, 55%, and 27%, respectively for I, II, III, and IV-V glossectomy group; CSS-5yrs was 82%, 80%, 72%, and 48%, respectively for I, II, III, and IV-V glossectomy group (p < 0.01).ConclusionsThis study confirmed that the application of the glossectomy classification was statistically correlated with patients' oncological outcomes. 相似文献
2.
3.
《Journal of stroke and cerebrovascular diseases》2022,31(10):106696
ObjectivesIntraventricular hemorrhage (IVH) is a subtype of stroke which has high mortality and morbidity, while comprehensive mechanism investigations and effective therapies are still in great need. Plenty of studies have shown that inflammation after stroke plays a critical role in disease outcomes. However, the inflammation after IVH remains unclear. This study aims to observe the immune response after IVH, thus providing therapeutic targets for IVH treatments.Materials and methodsIVH was induced by autologous blood infusion model in SD rats. Totally 588 rats were assigned either in the sham or IVH group. T2* lesion and hemoglobin quantities, ventricular volume, brain edema, ventricular wall damage, blood-brain-barrier (BBB) continuity and immune response were observed by magnetic resonance image (MRI), hematoxylin-eosin staining (HE), Evans Blue, flow cytometry (FACS), and enzyme-linked immunosorbent assay (ELISA) at baseline, 6 h, 1 d, 3 d, 7 d, 14 d after surgery.ResultsWe found that ventricular volume enlargement occurred hours after IVH and peaked at 3 d after IVH, then mildly reduced till 14 d. Similar changes happened in brain edema, ventricular wall damage and BBB leakage. Immune cells and cytokines in the central nervous system and peripheral blood also increased after IVH and experienced similar trends as ventricular enlargement. T2* lesion and hemoglobin degradation occurred 6 h after IVH and kept decreasing till 14 d after IVH.ConclusionsOur investigation illustrates that immune response exists after IVH, which may have a close relationship with disease outcomes. These results may provide promising immune related clues for mechanism and intervention studies in IVH. 相似文献
4.
5.
胶质瘤bcd—2基因表达水平与其细胞增殖和凋亡关系的研究 总被引:12,自引:0,他引:12
目的 探讨胶质瘤细胞bcl-2基因表达水平与肿瘤恶性程度、细胞增殖活性及凋亡程度的关系。方法 以69例不同级别的人胶质瘤组织为研究对象,用原位杂交及免疫组化染色ABC法分别检测bcl-2mRNA、bcl-2蛋白和增殖细胞核抗原(细胞增殖活性标记物)的表达,并用3’末标记法做原位细胞凋亡检测。结果 64例(92.8%)表达bcl-2mRNA,60例(87.0%)表达bcl-2蛋白,两者的表达水平呈正 相似文献
6.
生长抑制因子1基因核定位序列-绿荧光蛋白融合表达载体的构建及表达 总被引:1,自引:0,他引:1
目的构建p33^ING1b核定位序列(nuclear locating sequence,NLS)-绿荧光蛋白融合表达载体,将其转染到人胚肺纤维母细胞系MRC-5,建立稳定表达该融合蛋白的细胞模型。方法应用逆转录PCR获得p33^ING1b的NLS序列,然后将NLS序列插入绿荧光蛋白融合表达载体pEGFP-C1的多克隆位点,构建pEGFP-C1-NLS-绿荧光蛋白融合表达载体,再用此载体转染MRC-5细胞系,观察活细胞绿荧光蛋白的亚细胞定位。结果成功构建了pEGFP-C1-NLS-绿荧光蛋白融合表达载体,由该载体表达的绿荧光蛋白-NLS肽段融合蛋白产生的绿色荧光信号全部定位于胞核部位,而空载体转染的细胞表达的绿色荧光蛋白,绿色荧光信号定位于细胞浆中。结论在活细胞内,生理情况下p33^ING1b完全定位于细胞核,并且在其亚细胞定位的转运过程中,NLS肽段起着决定性作用。 相似文献
7.
《世界针灸杂志》2023,33(3):191-197
“Long COVID” is a sustained symptom following infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). According to recent statistics, at least 65 million people have long COVID, which poses a long-term threat to human health. The pathogenic mechanisms of coronavirus disease 2019 (COVID-19) are complex and affect multiple organs and systems. Common symptoms include palpitations, breathing difficulties, attention and memory deficits, fatigue, anxiety, and depression. It is difficult to achieve satisfactory treatment effect with a single intervention. Currently, treatment strategies for long COVID are still in the exploratory stage, and there is an urgent need to find appropriate and effective methods for long COVID treatment. Traditional Chinese medicine is effective in treating the various phases of COVID-19. Previous studies have shown that acupoint stimulation therapy is effective in improving palpitations, dyspnea, cognitive impairment, anxiety, depression, and other symptoms in patients. According to previous studies, acupoint stimulation may improve various symptoms related to long COVID. This paper discusses the potential application value of acupoint stimulation in the treatment of long COVID-related symptoms, based on the common sequelae of various systems involved in long COVID, and the effect of acupoint stimulation in the treatment of similar symptoms and diseases in recent years. 相似文献
8.
9.
10.